Page last updated: 2024-12-07

chromozym th

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chromozym TH: synthetic substrate for thrombin which acts on it to liberate p-nitroaniline (yellow color) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123649
SCHEMBL ID11528157
MeSH IDM0062926

Synonyms (13)

Synonym
chromozym th
61876-61-7
SCHEMBL11528157
l-argininamide, n-((4-methylphenyl)sulfonyl)glycyl-l-prolyl-n-(4-nitrophenyl)-, monohydrochloride
chr-th
tos-gly-pro-arg-p-nitroanilide
tosyl-glycyl-prolyl-arginyl-p-nitroanilide
tos-gly-pro-arg-pna
VJZRBVVLWLEXBB-VROPFNGYSA-N
DTXSID30977433
n-[5-carbamimidamido-1-(4-nitroanilino)-1-oxopentan-2-yl]-1-[n-(4-methylbenzene-1-sulfonyl)glycyl]pyrrolidine-2-carboximidic acid--hydrogen chloride (1/1)
(2s)-n-[(2s)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]-1-[2-[(4-methylphenyl)sulfonylamino]acetyl]pyrrolidine-2-carboxamide;hydrochloride
AKOS040751164
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (40)

TimeframeStudies, This Drug (%)All Drugs %
pre-199025 (62.50)18.7374
1990's11 (27.50)18.2507
2000's3 (7.50)29.6817
2010's1 (2.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 15.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index15.44 (24.57)
Research Supply Index3.83 (2.92)
Research Growth Index4.09 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (15.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]